Clinical Trial Update: Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma [Phase 2]

View source ↗

Summary

Phase 2 crossover study evaluating multiple doses of indacaterol for efficacy, safety, and tolerability in patients with persistent asthma; results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Indacaterol (indacaterol)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2015-05-06